Copyright
©2010 Baishideng.
World J Gastroenterol. Jun 28, 2010; 16(24): 3063-3071
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3063
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3063
Data source | Design | PF (º) | Sample capacity (LNF/LTF) | Group or subg. depend on EM | Follow-up (mo) | Level of evidence |
Mickevicius et al[22], 2008 | RCT | 200-270 | 76/77 | No detail | 12 | 1b Level A |
Fibbe et al[23], 2001 | ||||||
Zornig et al[24], 2002 | RCT | 270 | 100/100 | More subgroups | 24 | 1b Level A |
Strate et al[16], 2008 | ||||||
Chrysos et al[25], 2003 | RCT | 270 | 14/19 | Both abnormal | 12 | 2b Level B |
Guérin et al[26], 2007 | RCT | 270 | 77/63 | Normal-Nissen/Abnormal-Toupet | 36 | 1b Level A |
Laws et al[10], 1997 | RCT | 200 | 23/16 | Both normal | 27.2 | 2b Level B |
Shaw et al[27], 2010 | RCT | 270 | 50/50 | No detail | > 55 | 1b Level A |
Booth et al[21], 2008 | RCT | 270 | 64/63 | No detail | 12 | 1b Level A |
Coster et al[28], 1997 | PCT | No detail | 125/101 | No detail | 12 | 2b Level B |
Granderath et al[29], 2007 | PCT | 270 | 28/28 | Both normal | 3 | 3b Level B |
Wykypiel et al[30], 2008 | PCT | 300 | 20/20 | Normal-Nissen/Abnormal-Toupet | 6 | 3b Level B |
Hunter et al[31], 1996 | PCT | 180-300 | 101/83 | Both normal | 3 | 3b Level B |
Bessell et al[17], 2000 | PCT | 200-270 | 761/85 | More subgroups | 12 | 2b Level B |
Radajewski et al[32], 2009 | PCT | No detail | 51/43 | No detail | 12 | 2b Level B |
Kamolz et al[33], 2000 | PCT | No detail | 107/68 | No detail | 60 | 2b Level B |
Kamolz et al[11], 2002 | ||||||
Sgromo et al[34], 2008 | RT | No detail | 150/116 | No detail | 72 | 2b Level B |
Erenoğlu et al[35], 2003 | RT | 270 | 118/26 | Normal-Nissen/Abnormal-Toupet | 27.5 | 2b Level B |
Herbella et al[20], 2007 | RT | 240 | 55/16 | More subgroups | 16 | 3b Level B |
Wetscher et al[12], 1997 | RT | No detail | 17/32 | Normal-Nissen/Abnormal-Toupet | 15 | 3b Level B |
Fernando et al[36], 2002 | RT | 270 | 163/43 | No detail | 19.7 | 2b Level B |
Wykypiel et al[37], 2005 | RT | 300 | 77/132 | Normal-Nissen/Abnormal-Toupet | 52 | 2b Level B |
McKernan et al[38], 1994 | RT | 180-200 | 14/14 | No detail | > 3.4 | 3b Level B |
Fein et al[45], 2008 | RT | No detail | 88/10 | Normal-Nissen/Abnormal-Toupet | 120 | 2b Level B |
Patti et al[39], 2004 | RT | 240 | 216/141 | More subgroups | > 23 | 2b Level B |
Zügel et al[9], 2002 | RT | 270 | 40/122 | No detail | 19 | 2b Level B |
Pessaux et al[40], 2000 | RT | 180 | 1078/392 | No detail | 24 | 2b Level B |
Bell et al[41], 1996 | RT | 180 | 11/11 | No detail | 13 | 4 Level C |
Lund et al[42], 1997 | RT | 270 | 16/46 | Both abnormal | 6 | 3b Level B |
Farrell et al[43], 2000 | RT | 270 | 293/52 | More subgroups | 12 | 3b Level B |
Heider et al[44], 2003 | RT | 270 | 15/4 | Both abnormal | 29.5 | 4 Level C |
- Citation: Shan CX, Zhang W, Zheng XM, Jiang DZ, Liu S, Qiu M. Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol 2010; 16(24): 3063-3071
- URL: https://www.wjgnet.com/1007-9327/full/v16/i24/3063.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i24.3063